Icosapent ethyl and plaque regression: insights from the EVAPORATE-FFRCT study

Eur Heart J Cardiovasc Imaging. 2023 Jun 21;24(7):874-875. doi: 10.1093/ehjci/jead086.

Authors

Robert Sykes^{1

2}, Richard McFarlane^{1

2}

Affiliations

¹ School of Cardiovascular and Metabolic Health, University of Glasgow, BHF Glasgow Cardiovascular Research Centre, 126 University Place, Glasgow G12 8TA, UK.
² Department of Cardiology, The West of Scotland Regional Heart and Lung Centre, Golden Jubilee National Hospital, Agamemnon Street, Clydebank G81 4DY, UK.

PMID: 37119308
DOI: 10.1093/ehjci/jead086

No abstract available

Publication types

Editorial
Comment

MeSH terms

Computed Tomography Angiography
Fractional Flow Reserve, Myocardial*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Plaque, Atherosclerotic* / diagnostic imaging

Substances

eicosapentaenoic acid ethyl ester
Hydroxymethylglutaryl-CoA Reductase Inhibitors